Characteristics of Biological Treatment Failure in Patients With Severe Eosinophilic Asthma

被引：0
|
作者：
Zehr, E. [1 ]
Pomponio, R. [2 ]
Peterson, R. [2 ]
Reihman, A. E. [3 ]
Cruse, M. H. [3 ]
Hills, A. [3 ]
Likosky, K. [4 ]
Yamamura, M. K. [1 ]
Holguin, F. L. [3 ]
Sharma, S. [3 ]
机构：
[1] Univ Colorado, Dept Med, Aurora, CO USA
[2] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA
[3] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO USA
[4] Villanova Univ, Villanova, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5984
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Predictors of Biological Treatment Failure in Patients with Severe Eosinophilic Asthma
    Reihman, A. E.
    Pomponio, R.
    Peterson, R.
    Cruse, M.
    Hills, A.
    Likosky, K.
    Yamamura, M. K.
    Holguin, F.
    Sharma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [2] The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication
    Akaba, Tomohiro
    Kondo, Mitsuko
    Kurokawa, Atsushi
    Takeyama, Kiyoshi
    Tagaya, Etsuko
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Biological treatment is approved for severe eosinophilic asthma
    Mayor, Susan
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355 : i6472
  • [4] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) : 1198 - 1207
  • [5] Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic "Overlap" severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
    Tepetam, Fatma Merve
    Akyildiz, Ali Burkan
    Ozden, Seyma
    Orcen, Cihan
    Yakut, Tugce
    Atik, Ozge
    MEDICINE, 2023, 102 (18) : E33660
  • [6] Characteristics of patients with severe asthma who experienced treatment failure with omalizumab
    Akaba, Tomohiro
    Kondo, Mitsuko
    Kobayashi, Fumi
    Honda, Nahoko
    Muramatsu, Soshi
    Yagi, Osamitsu
    Takeyama, Kiyoshi
    Seo, Yukako
    Nonaka, Manabu
    Tagaya, Etsuko
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 68
  • [7] Characteristics of Severe Asthma Clinic Patients With Eosinophilic Granulomatosis With Polyangiitis
    Puan, Youxin
    Ong, Kheng Yong
    Tiew, Pei Yee
    Chen, Gabriel Xu Wen
    Teo, Neville Wei Yang
    Low, Andrea Hsiu Ling
    Wechsler, Michael E.
    Koh, Mariko Siyue
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02) : 361 - 368.e2
  • [8] Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
    Youngwoo Choi
    Duy Le Pham
    Dong-Hyun Lee
    So-Hee Lee
    Seung-Hyun Kim
    Hae-Sim Park
    Experimental & Molecular Medicine, 2018, 50 : 1 - 8
  • [9] Effect of biological therapies on the rate of exacerbations in patients with severe eosinophilic asthma
    Rojo-Tolosa, S.
    Menendez-Lobo, A.
    Perez-Ramirez, C.
    Sanchez-Martinez, J. A.
    Gonzalez-Gutierrez, M. V.
    Jimenez-Morales, A.
    Morales-Garcia, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [10] Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
    Choi, Youngwoo
    Duy Le Pham
    Lee, Dong-Hyun
    Lee, So-Hee
    Kim, Seung-Hyun
    Park, Hae-Sim
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 8
12345